Michele Bartoletti

1.4k total citations
54 papers, 575 citations indexed

About

Michele Bartoletti is a scholar working on Oncology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Michele Bartoletti has authored 54 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 16 papers in Reproductive Medicine and 16 papers in Cancer Research. Recurrent topics in Michele Bartoletti's work include Ovarian cancer diagnosis and treatment (16 papers), PARP inhibition in cancer therapy (9 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Michele Bartoletti is often cited by papers focused on Ovarian cancer diagnosis and treatment (16 papers), PARP inhibition in cancer therapy (9 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Michele Bartoletti collaborates with scholars based in Italy, United States and South Korea. Michele Bartoletti's co-authors include Fabio Puglisi, Lorenzo Gerratana, Giacomo Pelizzari, Debora Basile, C. Lisanti, Vincenzo Canzonieri, Davide Lombardi, Isabella Caligiuri, Paola Di Nardo and Silvio Ken Garattini and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Michele Bartoletti

49 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Bartoletti Italy 14 273 149 135 111 80 54 575
Chunyan Li China 15 208 0.8× 138 0.9× 225 1.7× 81 0.7× 21 0.3× 65 658
Wen Gao China 13 225 0.8× 186 1.2× 187 1.4× 47 0.4× 183 2.3× 51 717
Kyungmi Yang South Korea 13 117 0.4× 90 0.6× 254 1.9× 61 0.5× 17 0.2× 48 563
Dava J. Garcia United States 9 144 0.5× 59 0.4× 134 1.0× 38 0.3× 56 0.7× 16 448
Haoran Li China 14 336 1.2× 187 1.3× 491 3.6× 345 3.1× 91 1.1× 81 1.1k
Tianjian Lu China 5 332 1.2× 68 0.5× 218 1.6× 117 1.1× 26 0.3× 6 644
C. Lisanti Italy 9 312 1.1× 147 1.0× 321 2.4× 185 1.7× 7 0.1× 26 679
Danae Hamouda United States 11 230 0.8× 67 0.4× 156 1.2× 54 0.5× 26 0.3× 33 460

Countries citing papers authored by Michele Bartoletti

Since Specialization
Citations

This map shows the geographic impact of Michele Bartoletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Bartoletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Bartoletti more than expected).

Fields of papers citing papers by Michele Bartoletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Bartoletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Bartoletti. The network helps show where Michele Bartoletti may publish in the future.

Co-authorship network of co-authors of Michele Bartoletti

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Bartoletti. A scholar is included among the top collaborators of Michele Bartoletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Bartoletti. Michele Bartoletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartoletti, Michele, Serena Corsetti, Sara Cecco, et al.. (2025). Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer. Current Oncology. 32(11). 596–596.
2.
Pascale, Renato, Angelo Maccaro, Francesca Giovannenze, et al.. (2025). Treatment of Stenotrophomonas malthophilia bloodstream infections from guidance to real life: multicenter retrospective cohort study. Journal of Infection and Chemotherapy. 31(8). 102759–102759. 1 indexed citations
3.
Caligiuri, Isabella, Michele Bartoletti, Giuseppe Corona, et al.. (2025). Longitudinal prediction of drug response in high-grade serous ovarian cancer organoid cultures aligning with clinical responses. Journal of Advanced Research.
4.
Bartoletti, Michele, Marcella Montico, Domenica Lorusso, et al.. (2024). Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis. Cancer Treatment Reviews. 125. 102701–102701. 18 indexed citations
5.
Bartoletti, Michele, Ivan Bièche, Giuseppe Curigliano, et al.. (2024). Multi-Institutional Evaluation of Interrater Agreement of Biomarker-Drug Pair Rankings Based on the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) and Sources of Discordance. Molecular Diagnosis & Therapy. 29(1). 91–101. 1 indexed citations
6.
Caligiuri, Isabella, et al.. (2023). 3D dynamic cultures of HGSOC organoids to model innovative and standard therapies. Frontiers in Bioengineering and Biotechnology. 11. 1135374–1135374. 11 indexed citations
7.
Passarelli, Anna, Jole Ventriglia, Carmela Pisano, et al.. (2023). The way to precision medicine in gynecologic cancers: The first case report of an exceptional response to alpelisib in a PIK3CA-mutated endometrial cancer. Frontiers in Oncology. 12. 1088962–1088962. 5 indexed citations
8.
9.
Gerratana, Lorenzo, Marcella Montico, Bianca Posocco, et al.. (2023). Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer. Biomedicine & Pharmacotherapy. 167. 115479–115479. 9 indexed citations
10.
Asif, Kanwal, Muhammad Adeel, Md. Mahbubur Rahman, et al.. (2023). Silver nitroprusside as an efficient chemodynamic therapeutic agent and a peroxynitrite nanogenerator for targeted cancer therapies. Journal of Advanced Research. 56. 43–56. 21 indexed citations
11.
Bartoletti, Michele, Alice Bergamini, Gaia Giannone, et al.. (2022). A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group. International Journal of Gynecological Cancer. 32(9). 1205–1207. 4 indexed citations
12.
Musacchio, Lucia, Vanda Salutari, Giorgio Valabrega, et al.. (2022). MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis. Cancer Treatment Reviews. 110. 102458–102458. 3 indexed citations
13.
Passarelli, Anna, Carmela Pisano, Sabrina Chiara Cecere, et al.. (2022). Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer. Frontiers in Immunology. 13. 953115–953115. 18 indexed citations
14.
Parisse, Pietro, Michele Bartoletti, Vincenzo Canzonieri, et al.. (2021). Cell-stiffness and morphological architectural patterns in clinical samples of high grade serous ovarian cancers. Nanomedicine Nanotechnology Biology and Medicine. 37. 102452–102452. 12 indexed citations
15.
Bartoletti, Michele, Roberta Mazzeo, Maria Grazia Vitale, et al.. (2020). Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget’s disease of the vulva. International Journal of Gynecological Cancer. 30(11). 1672–1677. 18 indexed citations
16.
Gagno, Sara, Elena Poletto, Michele Bartoletti, et al.. (2019). A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer. Gynecologic Oncology. 156(1). 233–242. 4 indexed citations
17.
Pelizzari, Giacomo, Lorenzo Gerratana, Debora Basile, et al.. (2018). Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation. Cancer Treatment Reviews. 72. 7–14. 21 indexed citations
18.
Gerratana, Lorenzo, Debora Basile, Maria Grazia Vitale, et al.. (2018). Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study. Journal of Cancer Research and Clinical Oncology. 144(10). 2029–2047. 13 indexed citations
19.
Bonotto, Marta, Debora Basile, Lorenzo Gerratana, et al.. (2018). Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey. The Breast. 40. 45–52. 6 indexed citations
20.
Macerelli, Marianna, Alessandro Del Conte, Laura Bonanno, et al.. (2017). Clinical features of never smoker patients with lung squamous cell carcinoma: a retrospective multicenter study. Annals of Oncology. 28. vi60–vi60. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunyan Li Breakdown of academic impact, for papers by Wen Gao Breakdown of academic impact, for papers by Kyungmi Yang Breakdown of academic impact, for papers by Dava J. Garcia Breakdown of academic impact, for papers by Haoran Li Breakdown of academic impact, for papers by Tianjian Lu Breakdown of academic impact, for papers by C. Lisanti Breakdown of academic impact, for papers by Danae Hamouda
Rankless by CCL
2026